4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
ASKA Pharmaceutical Holdings Co.,Ltd. (4886) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Tokyo, Japan with about 1,611 employees. Its market capitalization is roughly JPY 58 billion. In the fiscal year ended 2026-03-31, 4886 reported JPY 71.1B in revenue and JPY 5.4B in net income.
ASKA Pharmaceutical Holdings Co.,Ltd., through its subsidiaries, engages in the pharmaceutical, animal health, and other businesses in Japan.
Interactive charts & full statements →
| Income statement | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Total Revenue | JPY 71.1B | JPY 64.1B | JPY 62.8B | JPY 60.5B |
| Gross Profit | JPY 34.1B | JPY 31.3B | JPY 30.7B | JPY 28.6B |
| Operating Income (EBIT) | JPY 5.8B | JPY 5.3B | JPY 6.5B | JPY 5.1B |
| Net Income | JPY 5.4B | JPY 5.1B | JPY 7.5B | JPY 4.2B |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Dividends Paid | (JPY 24M) | (JPY 1.3B) | (JPY 22M) | (JPY 452M) | — |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Assets | JPY 112.4B | JPY 104.3B | JPY 90.7B | JPY 87.1B | — |
| Total Liabilities | JPY 35.6B | JPY 32.5B | JPY 28.8B | JPY 32.6B | — |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 4886 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms